(Q41361915)

29 September 2017

1 reference

title

The assessment of refill compliance using pharmacy records: methods, validity, and applications (English)

1 reference

29 September 2017

0 references

J F Steiner

1

1 reference

29 September 2017

A V Prochazka

series ordinal

2

1 reference

29 September 2017

publication date

1 January 1997

1 reference

Journal of Clinical Epidemiology

29 September 2017

published in

1 reference

29 September 2017

volume

50

1 reference

29 September 2017

issue

1

1 reference

29 September 2017

page(s)

105-116

1 reference

Primary non-compliance with prescribed medication in primary care

29 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2896%2900268-5

7 January 2021

Measurement of patient compliance and the interpretation of randomized clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2896%2900268-5

7 January 2021

In Search of the Gold Standard for Compliance Measurement

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2896%2900268-5

7 January 2021

Improved compliance measures: applications in an ambulatory hypertensive drug trial

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2896%2900268-5

7 January 2021

The rational clinical examination. Is this patient taking the treatment as prescribed?

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2896%2900268-5

7 January 2021

A general method of compliance assessment using centralized pharmacy records. Description and validation

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2896%2900268-5

7 January 2021

Reduction of polypharmacy by feedback to clinicians

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2896%2900268-5

7 January 2021

Appropriate reductions in compliance among well-controlled hypertensive patients

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2896%2900268-5

7 January 2021

The effect of prescription size on acquisition of maintenance medications

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2896%2900268-5

7 January 2021

Drug Defaulting in a General Practice

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2896%2900268-5

7 January 2021

Estimating a patient??s cooperation with his regimen

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2896%2900268-5

7 January 2021

Variations in patient compliance with common long-term drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2896%2900268-5

7 January 2021

Patient Report Validated against Prescription Records for Measuring Use of and Compliance with Antihypertensive Drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2896%2900268-5

7 January 2021

Role of the clinical pharmacist in improving drug therapy. Clinical pharmacists in outpatient therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2896%2900268-5

7 January 2021

Determinants of Patient Compliance with Anticonvulsant Therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2896%2900268-5

7 January 2021

Sustained improvement in drug documentation, compliance, and disease control. A four-year analysis of an ambulatory care model

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2896%2900268-5

7 January 2021

Age as a major factor affecting adherence to medication for hypertension in a general practice population

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2896%2900268-5

7 January 2021

Underutilization of antihypertensive drugs and associated hospitalization

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2896%2900268-5

7 January 2021

The relative risk of incident coronary heart disease associated with recently stopping the use of beta-blockers

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2896%2900268-5

7 January 2021

The Effects of Monitoring and Feedback on Compliance

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2896%2900268-5

7 January 2021

Adequacy and duration of antidepressant treatment in primary care

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2896%2900268-5

7 January 2021

Treatment for glaucoma: adherence by the elderly

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2896%2900268-5

7 January 2021

Evaluation of a medication refill reminder system for a community pharmacy

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2896%2900268-5

7 January 2021

Evaluation of a computerized reminder system in the enhancement of patient medication refill compliance

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2896%2900268-5

7 January 2021

Patterns of antidepressant use in community practice

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2896%2900268-5

7 January 2021

Effect of value-added utilities on prescription refill compliance and Medicaid health care expenditures--a study of patients with non-insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2896%2900268-5

7 January 2021

Noncompliance with congestive heart failure therapy in the elderly

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2896%2900268-5

7 January 2021

The costs of interrupting antihypertensive drug therapy in a Medicaid population.

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2896%2900268-5

7 January 2021

A Study Design for Comparing the Effects of Missing Daily Doses of Antihypertensive Drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2896%2900268-5

7 January 2021

The role of automated record linkage in the postmarketing surveillance of drug safety: a critique

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2896%2900268-5

7 January 2021

A study of the effects of exposure misclassification due to the time-window design in pharmacoepidemiologic studies.

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2896%2900268-5

7 January 2021

Rapid method for estimating the risk of acutely controversial side effects of prescription drugs.

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2896%2900268-5

7 January 2021

Diuretic therapy for hypertension and the risk of primary cardiac arrest

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2896%2900268-5

7 January 2021

Psychotropic drug use and the risk of hip fracture

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2896%2900268-5

7 January 2021

10.1016/S0895-4356(96)00268-5

Identifiers

DOI

1 reference

release_xijeldt2xzgipeuecz3ptu5gem

29 September 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/xijeldt2xzgipeuecz3ptu5gem

24 November 2022

mapped directly with Wikidata item

1 reference